Abstract
In recent years, supramolecular micellar assemblies formed from amphiphilic block copolymers have been receiving attention as potential drug carriers. The size of the carriers is ideal for avoiding rapid renal exclusion and reticuloendothelial uptake, and enables them to be targeted to certain tissues such as tumors. One important issue determining the effectiveness of a micellar drug carrier is the ability to control the time over which drug release takes place, or to possibly trigger drug release at a specific location or time. The mildly acidic pH encountered in tumor and inflammatory tissues as well as in the endosomal and lysosomal compartments of cells has inspired the development of micellar carriers capable of releasing their drug load in response to small changes in pH. One approach to the development of these systems has been to incorporate "titratable" groups such as amines and carboxylic acids into the copolymer backbone, thus altering the solubility of the polymer upon protonation and disrupting micelle formation. Another approach has been to incorporate aciddegradable linkages into the copolymer, either for direct attachment of the drug, or to cause a structural change of such magnitude that micellar integrity is lost and the drug is released.
Original language | English (US) |
---|---|
Pages (from-to) | 1295-1307 |
Number of pages | 13 |
Journal | Pure and Applied Chemistry |
Volume | 76 |
Issue number | 7-8 |
DOIs | |
State | Published - 2004 |
Externally published | Yes |
Bibliographical note
Funding Information:The Center for New Directions in Organic Synthesis is supported by Bristol-Myers Squibb as a Sponsoring Member and Novartis Pharma as Supporting Member. We thank the National Institute of Health (GM 65361 and EB 002047) and the U.S. Department of Energy (DE-AC03-765F00098) for support of this research.
ASJC Scopus subject areas
- General Chemistry
- General Chemical Engineering